Compositions, organisms and methodologies employing a novel...

Details Compositions, organisms and methodologies employing a novel... Compositions, organisms and methodologies employing a novel...

2006-08-17

2008-08-05

Saidha, Tekchand (Department: 1652)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

C435S194000, C536S023200

Reexamination Certificate

active

07407792

ABSTRACT:
This invention provides compositions, organisms and methodologies employing a novel human protein kinase, HPK3P23. The novel human kinase has sequence homology to the catalytic domains of several protein kinases. The gene encoding this novel protein kinase is localized in or near the 3p23 locus of the human chromosome 3. The sequence similarity between the novel human protein and the catalytic domain of protein kinases indicates that the novel human protein may function as a protein kinase.

REFERENCES:
patent: 4489710 (1984-12-01), Spitler
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4569789 (1986-02-01), Blattler et al.
patent: 4625014 (1986-11-01), Senter et al.
patent: 4638045 (1987-01-01), Kohn et al.
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4751180 (1988-06-01), Cousens et al.
patent: 4935233 (1990-06-01), Bell et al.
patent: 5459039 (1995-10-01), Modrich et al.
patent: 5498531 (1996-03-01), Jarrell
patent: 5919619 (1999-07-01), Tullis
patent: 6506559 (2003-01-01), Fire et al.
patent: 6759222 (2004-07-01), Meyers
patent: 2004/0038881 (2004-02-01), Bandman et al.
patent: 2004/0197792 (2004-10-01), Whyte et al.
patent: 89/10134 (1989-11-01), None
patent: 97/07668 (1997-03-01), None
patent: 97/07669 (1997-03-01), None
patent: 99/14346 (1999-03-01), None
patent: 99/27132 (1999-06-01), None
patent: 00/44895 (2000-08-01), None
patent: 00/63364 (2000-10-01), None
patent: 00/73469 (2000-12-01), None
patent: 01/29058 (2001-04-01), None
patent: 01/36646 (2001-05-01), None
patent: 01/66594 (2001-09-01), None
patent: 01/68836 (2001-09-01), None
patent: 01/70949 (2001-09-01), None
patent: 01/75067 (2001-10-01), None
patent: 01/75164 (2001-10-01), None
patent: 01/92513 (2001-12-01), None
patent: 02/08399 (2002-01-01), None
patent: 02/18557 (2002-03-01), None
patent: 02/24924 (2002-03-01), None
patent: 02/46384 (2002-06-01), None
patent: 02/081731 (2002-10-01), None
patent: 03/050084 (2003-06-01), None
patent: 2004/032877 (2004-04-01), None
20040197792 [Applicants' SEQ ID No. 1 Vs SEQ ID No. 27 from Published Application 20040197792].
Altschul et al., “Gapped Blast and Psi-Blast: A New Generation of Protein Database Search Programs,”Nucleic Acids Research, 1997, pp. 3389-3402, vol. 25, No. 17, Oxford University Press.
Berger P. et al., “Loss of Phosphatase Activity in Myotubularin-Related Protein 2 is Associated with Charcot-Marie Tooth Disease Type 4B1,”Human Molecular Genetics, 2002, pp. 1569-1579, vol. 11, No. 13, Oxford University Press.
Boe R. et al., “The Protein Phosphatase Inhibitor Okadaic Acid Induces Morphological Changes Typical of Apoptosis in Mammalian Cells,”Experimental Cell Research, 195, 1991, pp. 237-246, Academic Press, Inc.
Bottim N, et al., “Low-Molecular-Weight Protein Tyrosine Phosphatase and Human Disease: In Search of Biochemical Mechanisms,”Archivum Immunologiae Et Therapiae Experimentalis, 2002 pp. 95-104, vol. 50.
Brown-Shimer, et al., “Effect Of Protein Tyrosine Phosphatase 1B Expression on Transformation by the Human Neu Oncogene,”Cancer Research, 52, 1992, pp. 478-548.
Chen et al., “The Myotonic Dystrophy Kinase-Related Cdc42—Binding Kinase is Involved in the Regulation of Neurite Outgrowth in PCI2 Cells,”The Journal of Biological Chemistry,1999, pp. 19901-19905, vol. 274, No. 28, The American Society For Biochemistry And Molecular Biology, Inc.
Delagrave et al., “Recursive Ensemble Mutagenesis,”Protein Engineering, 1993, pp. 327-331, vol. 6, No. 3, Oxford University Press.
Dong et al., “Cdc42 Antagonizes Inductive Action of cAMP on Cell Shape, via Effects of the Myotonic Dystrophy Kinase-Related Cdc42-Binding Kinase (MRCK) on Myosin Light Chain Phosphorylation,”European Journal of Cell Biology, Apr. 2002, pp. 231-242, vol. 81.
Engelman et al., “Identifying Nonpolar Transbilayer Helices in Amino Acid Sequences of Membrane Proteins,”Ann. Rev. Biophys. Chem., 1986, pp. 321-353, vol. 15, Annual Reviews Inc.
Florea et al., “A Computer Program for Aligning a cDNA Sequence with a Genomic DNA Sequence,”Genome Research, 1998, pp. 967-974, vol. 8, Cold Spring Harbor Laboratory Press.
Gossen et al., “Transcriptional Activation by Tetracyclines in Mammalian Cells,”Science, Jun. 23, 1995, pp. 1766-1769, vol. 268.
Guatelli et al., “Isothermal, in Vitro Amplification of Nucleic Acids by a Multienzyme Reaction Modeled After Retroviral Replication,”Proc. Natl. Acad. Sci. USA, Mar. 1990, pp. 1874-1878, vol. 87.
Haseloff et al., “Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities,”Nature, Aug. 18, 1988, pp. 585-591, vol. 334.
Hyrup et al., “Peptide Nucleic Acids (PNA): Synthesis, Properties and Potential Applications,”Bioorganic&Medicinal Chemistry, 1996, pp. 5-23, vol. 4, No. 1, Elsevier Science Ltd., Great Britain.
Ishida et al., “Treatment of Myeloid Leukemic Cells with the Phosphatase Inhibitor Okadaic Acid Induces Cell Cycle Arrest at Either G1/S or G2/M Depending on Dose,”Journal of Cellular Physiology, 1992, pp. 484-492.
Janssens et al., “Protein Phosphatase 2A: A Highly Regulated Family of Serine/Threonine Phosphatases Implicated in Cell Growth and Signaling,”J. Biochem, 353, 2001, pp. 417-443.
Kedra et al., “The Germinal Center Kinase Gene and a Novel Cdc25-Like Gene are Located in the Vicinity of the Pygm Gene on 11q13,”Hum. Genet., 1997, pp. 611-619, vol. 100.
Keen et al., “Rapid Detection of Single Base Mismatches as Heteroduplexes on Hydrolink Gels,”Trends in Genetics, 1997, p. 5, vol. 7.
Kwoh et al., “Transcription-Based Amplification System and Detection of Amplified Human Immunodeficiency Virus Type 1 with a Bead-Based Sandwich Hybridization Format,”Proc. Natl. Acad. Sci. USA, Feb. 1989, pp. 1173-1177, vol. 86.
Lam et al., “Characterization of a Monoclonal Antibody Panel Shows that the Myotonic Dystrophy Protein Kinase, DMPK, is Expressed Almost Exclusively in Muscle and Heart,”Human Molecular Genetics, 2000, pp. 2167-2173, vol. 9, No. 4, Oxford University Press.
Lee et al., “Expression of Small Interfering RNAs Targeted Against HIV-1 Rev Transcripts in Human Cells,”Nature Biotechnology, May 2002, pp. 500-505, vol. 19.
Leung et al., “Myotonic Dystrophy Kinase-Related Cdc42-Binding Kinase Acts as a Cdc42 Effector in Promoting Cytoskeletal Reorganization,”Molecular and Cellular Biology, Jan. 1998, pp. 130-140, vol. 18, No. 1, American Society For Microbiology.
Lizardi et al., “Exponential Amplification of Recombinant-RNA Hybridization Probes,”Biotechnology, Oct. 1988, pp. 1197-1202, vol. 6.
Maratea et al., “Deletion and Fusion Analysis of the Phage Øx174 Lysis Gene E,”Gene, 1985, pp. 39-46, vol. 40, Elsevier Science Publishers.
Meyers et al., “Optimal Alignments in Linear Space,”Cabios, 1988, pp. 11-17, vol. 4, No. 1, Press Limited, Oxford England.
Murphy et al., “Genetic Construction, Expression, and Melanoma-Selective Cytotoxicity of a Diphtheria Toxin-Related α-Melanoma-Stimulating Hormone Fusion Protein,”Proc. Natl. Aca. Sci. USA, Nov. 1986, pp. 8258-8262, vol. 83.
Needleman et al., “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Tow Proteins,”J. Mol. Bio., 1970, pp. 443-453, vol. 48.
No et al., “Ecdysone-Inducible Gene Expression in Mammalian Cells and Transgenic Mice,”Proc. Natl. Acad. Sci. USA, Apr. 1996, pp. 3346-3351, vol. 93.
Nomura et al., “Enhancement by Cyclosporin a of Taxol-Induced Apoptosis of Human Urinary Bladder Cancer Cells,”Urol Res, 2002, pp. 102-111, vol. 30.
O'gorman et al., “Recombinase-Mediated Gene Activation and Site-Specific Integration in Mammalian Cells,”Science, Mar. 1991, pp. 1351-1355, vol. 251.
Rosenbaum et al., “Temperature-Gradient Gel Electrophoresis,”Biophysical Chemistry, 1987, pp. 12

Affiliated with

Also associated with

Rating

Compositions, organisms and methodologies employing a novel... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions, organisms and methodologies employing a novel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions, organisms and methodologies employing a novel... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4016373